CHRISTINA NGUYEN: Open Payments
NPI 1437899432 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 10 payments from 7 companies in 2025. Trend: 2023 $763 · 2024 $398 · 2025 $766
Food & beverage: $691Education: $75
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 2 | $250 |
| Incyte Corporation | 2 | $150 |
| ABBVIE INC. | 1 | $125 |
| Astellas Pharma US Inc | 2 | $104 |
| SANOFI US SERVICES INC. | 1 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
Products named: REZUROCK, Niktimvo, LIVTENCITY, Cresemba, Exparel.
Industry payments across TX — which companies pay providers there.
